MucoCept: a Live Topical Microbicide for Women

MucoCept：女性局部用活杀微生物剂

• 批准号: 7239681
• 负责人: Qiang Xu
• 金额: $ 57.48万
• 依托单位: OSEL, INC.
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-06-15 至 2009-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7239681
• 关键词: A Mouse; AIDS/HIV problem; Adherence; Anaerobic Bacteria; Antibiotics; Bacterial Chromosomes; Bacterial Vaginosis; Bacteriophages; Biological Preservation; Biological Products; Cervical; Characteristics; Clinical Trials; Cyanovirin-N; Development; Disabled Persons; Disease; Disruption; Doctor of Philosophy; Drug Formulations; Ecology; Environment; Epithelium; Fermentation; Generations; Genes; Genitourinary system; Genome Stability; Gonorrhea; Growth; Guanosine Monophosphate; HIV; HIV-1; Health; Heterosexuals; Human; Hydrogen Peroxide; In Situ; In Vitro; Incidence; Lactic acid; Lactobacillus; Lead; Length; Life; Local Microbicides; Macaca; Medical; Modeling; Mucous Membrane; Mus; Opportunistic Infections; Organism; Oryctolagus cuniculus; Pelvic Inflammatory Disease; Phase I Clinical Trials; Phenotype; Play; Positioning Attribute; Pregnancy Outcome; Prevention; Primates; Production; Program Development; Proteins; Rate; Recurrence; Research Personnel; Risk; Role; Safety; Sexually Transmitted Diseases; Site; Syndrome; Technology; Testing; Therapeutic; Toxicology; United States Food and Drug Administration; Urinary tract infection; Vagina; Woman; Work; antimicrobial; capsule; design; experience; immunogenicity; improved; in vivo; inhibitor/antagonist; innovation; irritation; microbial community; nonhuman primate; novel therapeutics; pathogen; pre-clinical; prevent; prototype; simian human immunodeficiency virus; transmission process; vaginal lactobacilli